Literature DB >> 6151899

Induction of the nuclear protein 'cyclin' in quiescent mouse 3T3 cells stimulated by serum and growth factors. Correlation with DNA synthesis.

R Bravo, H Macdonald-Bravo.   

Abstract

The effect of serum and growth factors [platelet-derived growth factor (PDGF), fibroblast growth factor (FGF)] on the synthesis of the nuclear protein cyclin and its correlation with DNA synthesis has been studied in quiescent mouse 3T3 cells by means of quantitative two-dimensional gel electrophoresis. Serum must be present in the medium for at least 8-12 h to induce maximal synthesis of cyclin (6- to 7-fold increase compared with quiescent cells). The stimulation of cyclin synthesis is dose-dependent and correlates directly with DNA synthesis. In addition, partially purified PDGF and FGF also induce cyclin and DNA synthesis in a coordinate way. Both growth factors, like serum, exhibit a similar lag phase to induce maximal cyclin (6- to 7-fold) and DNA synthesis (90% of the cells). Pure PDGF at a concentration as low as 10 ng/ml has the same effect as 10% serum. The coordinate induction of cyclin and DNA synthesis can only be observed with growth factors that induce DNA synthesis. These results strengthen the notion that cyclin is an essential component of the events leading to DNA replication.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151899      PMCID: PMC557835          DOI: 10.1002/j.1460-2075.1984.tb02276.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  17 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells.

Authors:  A Aharonov; R M Pruss; H R Herschman
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

3.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Production and characterization of mammalian cells reversibly arrested in G1 by growth in isoleucine-deficient medium.

Authors:  R A Tobey
Journal:  Methods Cell Biol       Date:  1973       Impact factor: 1.441

5.  Production and characterization of antibody blocking epidermal growth factor:receptor interactions.

Authors:  H T Haigler; G Carpenter
Journal:  Biochim Biophys Acta       Date:  1980-05-23

6.  Gene expression in normal and virally transformed mouse 3T3b and hamster BHK21 cells.

Authors:  R Bravo; J E Celis
Journal:  Exp Cell Res       Date:  1980-06       Impact factor: 3.905

7.  Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation.

Authors:  R Bravo; S J Fey; J Bellatin; P M Larsen; J Arevalo; J E Celis
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

8.  Distribution of HeLa cells polypeptides in cytoplasts and karyoplasts.

Authors:  R Bravo; A Celis; D Mosses; J E Celis
Journal:  Cell Biol Int Rep       Date:  1981-05

9.  Gene expression in murine hybrids exhibiting different morphologies and tumorigenic properties.

Authors:  R Bravo; S J Fey; J E Celis
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

10.  A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells.

Authors:  R Bravo; J E Celis
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

View more
  23 in total

1.  An inhibitor of the in vitro elongation reaction of simian virus 40 DNA replication is overcome by proliferating-cell nuclear antigen.

Authors:  S H Lee; Y Ishimi; M K Kenny; P Bullock; F B Dean; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 2.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Proliferation-associated nuclear antigen p105 as a marker for metastasis of human gastric cancer.

Authors:  S Ohyama; Y Yonemura; H Kimura; T Kosaka; I Miyazaki; T Sasaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a mycobacterial antigen.

Authors:  H M Haftel; Y Chang; R Hinderer; S M Hanash; J Holoshitz
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

6.  The gene for proliferating cell nuclear antigen (Pcna) maps to mouse chromosome 2.

Authors:  C Abbott; A Pilz; H Moseley; J Peter
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

7.  Molecular characterisation and stage-specific expression of proliferating cell nuclear antigen (PCNA) from the malarial parasite, Plasmodium falciparum.

Authors:  B J Kilbey; I Fraser; S McAleese; M Goman; R G Ridley
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

8.  A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.

Authors:  C Labrie; G F Morris; M B Mathews
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Effects of selected chemotherapeutic agents on PCNA expression in prostate carcinoma cell lines.

Authors:  L Qiao; G Pizzolo; M R Melamed
Journal:  Urol Res       Date:  1994

10.  Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins.

Authors:  J M Almendral; D Huebsch; P A Blundell; H Macdonald-Bravo; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.